STADA Competitors and Similar CompaniesClear all
STADA's competitors and similar companies include SciClone Pharmaceuticals, Aquestive Therapeutics, Karyopharm Therapeutics and Sol-Gel Technologies.
 SciClone Pharmaceuticals SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. |  Aquestive Therapeutics Aquestive Therapeutics is a pharmaceutical company that is engaged in drug development using PharmFilm technology. |  Karyopharm Therapeutics Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies. |  Sol-Gel Technologies Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals. | ||
Founding Date | Founding Date 1895 | Founding Date 1989 | Founding Date 2004 | Founding Date 2008 | Founding Date 1997 |
Type | Type Public | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Bad Vilbel, DE HQ Beijing, CN Hangzhou Shi, CN Shanghai, CN Bad Vilbel, DE Budapest, HU Vilnius, LT see more | Locations Foster City, US HQ | Locations Warren, US HQ | Locations Newton, US HQ Givatayim, IL | Locations Ness Ziona, IL HQ |
Employees | Employees 12,33911% increase | Employees 1102% decrease | Employees 13017% decrease | Employees 22818% decrease | Employees 34 |
Valuation ($) | Valuation ($) 6 b | Valuation ($) N/A | Valuation ($) 515.4 m | Valuation ($) 111.7 m | Valuation ($) 18 m |
Financial | |||||
Revenue (est.) | Revenue (est.) €3b (FY, 2020) | Revenue (est.) $160.1m (FY, 2016) | Revenue (est.) $44.5m (FY, 2025) | Revenue (est.) $146.1m (FY, 2025) | Revenue (est.) $19.4m (FY, 2025) |
Cost of goods | Cost of goods €1.3b (FY, 2020) | Cost of goods N/A | Cost of goods $18.6m (FY, 2025) | Cost of goods $5.9m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit €1.7b (FY, 2020) | Gross profit N/A | Gross profit $26m (FY, 2025) | Gross profit $140.1m (FY, 2025) | Gross profit $19.4m (FY, 2025) |
Net income | Net income €181.9m (FY, 2020) | Net income $30.7m (FY, 2016) | Net income ($83.8m) (FY, 2025) | Net income ($196m) (FY, 2025) | Net income ($6.1m) (FY, 2025) |
Operating ⚠ | |||||
Patents (US) | Patents (US) 2 (Nov, 2020) | Patents (US) N/A | Patents (US) 40 (Q1, 2018) | Patents (US) N/A | Patents (US) N/A |
Patents Issued | Patents Issued N/A | Patents Issued N/A | Patents Issued 200 (Q1, 2018) | Patents Issued 10 (FY, 2015) | Patents Issued N/A |
For sources of this data, please see the company profile
View Company Profiles
SciClone Pharmaceuticals
HQ
Foster City, US
Employees
110↓ 2% decrease
SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders.
View companyAquestive Therapeutics
HQ
Warren, US
Employees
130↓ 17% decrease
Aquestive Therapeutics is a pharmaceutical company that is engaged in drug development using PharmFilm technology.
View companyKaryopharm Therapeutics
HQ
Newton, US
Employees
228↓ 18% decrease
Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies.
View companySol-Gel Technologies
HQ
Ness Ziona, IL
Employees
34
Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals.
View company